Context Therapeutics sells 14.7M shares for ~$15M to MPM BioImpact

Context Therapeutics Inc.

Sold 14,705,882 shares at ~$1.02/share for aggregate gross proceeds of ~$15M.
Shares purchased by MPM BioImpact LLC under sales agreement with Leerink Partners dated Dec 2, 2024.
Proceeds expected to fund working capital and general corporate purposes.

item 8.01

Context Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001842952-24-000087

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.